Hot Investor Mandate: USA-Based VC Firm with Large Incubator Space Invests in Seed to Series A Rounds, Considers All Biopharmaceuticals

27 May

A USA-based firm invests in early-stage biotech and pharma companies, mostly investing in seed to Series A rounds while it can also provide later funding (follow-up investment). The firm also seeks to In-licensing and NewCo spinout for later-stage research projects. The firm also has 30,000+ square feet of chemistry/biology incubator space.

The firm mainly looks at biopharmaceutical industry. The firm prefers to work closely with scientific innovators to advance discoveries rapidly through key value-inflection points.

The firm is seeking Seed to pre-IPO research-based U.S. companies developing novel drugs and biologics, with an underlying technology platform.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: